Risks and implications for health and the environment associated with products and waste containing nanomaterials: regulatory and management issues in the European framework

被引:0
|
作者
Zamengo, Luca [1 ]
Nasello, Mariano [2 ]
Branchi, Barbara [3 ]
Bracalente, Giulio [4 ]
Vergari, Walter [4 ]
Bertocco, Cesare [4 ]
Costernaro, Andrea [4 ]
机构
[1] Azienda ULSS 3 Serenissima, Lab Environm Hyg & Forens Toxicol LIATF, Veneto Region, Italy
[2] Hlth Protect Agcy Brianza, Prevent Lab, Lombardy Region, Italy
[3] Reg Agcy Prevent Environm & Energy Emilia Romagna, Water Analyt Unit, Romagna, Italy
[4] Univ Padua, Specializat Sch Chem Risk Assessment & Management, Dept Chem Sci, Padua, Italy
关键词
nanomaterials; nanomaterials-containing products; waste management; nanomaterials-containing waste; risk assessment; ENGINEERED NANOMATERIALS; NANOPARTICLES; DEFINITION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nanomaterials can revolutionize everyday products, but there are still many unanswered questions about the risks they may pose to human health and the environment. Inconsistent definitions and metrological issues are still of concern for manufacturers, importers and distributors who are demanded to comply with strict regulations. It is also likely that the increasing number of nanomaterial-containing products available on the market will vary the chemical and physical properties of the waste produced, which is currently treated in traditional plants without any particular differentiation. Treatment efficiency for nanomaterials-containing waste should then be addressed and the risks of uncontrolled emissions considered. Finally, the risks associated with the use of nanomaterials-containing products may not be sufficiently characterized as current exposure estimation models are not designed for estimating exposure to nanomaterials and they are likely to be affected by large uncertainties. Hence, it would be important for national and international institutions to provide, as soon as possible, harmonized regulations covering all aspects of the life cycle of products and waste containing nanomaterials. This paper is proposed as a starting point for reflection on the main regulatory and management issues associated with products and waste containing nanomaterials, focusing mainly on the European framework.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 27 条
  • [21] Adherence to safety practices and risks associated with health care waste management at an academic hospital, Pretoria, South Africa
    Mugivhisa, Liziwe Lizbeth
    Dlamini, Nokuthula
    Olowoyo, Joshua Oluwole
    AFRICAN HEALTH SCIENCES, 2020, 20 (01) : 453 - 468
  • [22] Urgent health concerns: Clinical issues associated with accidental ingestion of new metal-blade-containing sticks for heated tobacco products
    Moro, Paola Angela
    Maida, Francesca
    Solimini, Renata
    Spizzichino, Lorenzo
    Pauwels, Charlotte G. G. M.
    Pieper, Elke
    Havermans, Anne
    TOBACCO PREVENTION & CESSATION, 2024, 10
  • [23] The Potential of Remedial Techniques for Hazard Reduction of Steel Process by Products: Impact on Steel Processing, Waste Management, the Environment and Risk to Human Health
    Rodgers, Kiri
    McLellan, Iain
    Cuthbert, Simon
    Masaguer Torres, Victoria
    Hursthouse, Andrew
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (12)
  • [24] The pandemic of COVID-19 and its implications for the purity and authenticity of alcohol-based hand sanitizers: The health risks associated with falsified sanitizers and recommendations for regulatory and public health bodies
    Jairoun, Ammar Abdulrahman
    Al-Hemyari, Sabaa Saleh
    Shahwan, Moyad
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (01): : 2050 - 2051
  • [25] Systematic literature review of heavy metal contamination of the Nigerian environment from e-waste management: Associated health and carcinogenic risk assessment
    Owonikoko, W. M.
    Alimba, C. G.
    TOXICOLOGY, 2024, 505
  • [26] Health-related quality of life (HR-QOL) and regulatory issues - An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval
    Apolone, G
    De Carli, G
    Brunetti, M
    Garattini, S
    PHARMACOECONOMICS, 2001, 19 (02) : 187 - 195
  • [27] Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management A statement of the ESC Association of Cardiovascular Nursing and Allied Professions (ACNAP), the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association of Preventive Cardiology (EAPC), Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), European Association of Cardiovascular Imaging (EACVI), ESC Regulatory Affairs Committee, ESC Advocacy Committee, ESC Digital Health Committee, ESC Education Committee, and the ESC Patient Forum
    Moons, Philip
    Norekval, Tone M.
    Arbelo, Elena
    Borregaard, Britt
    Casadei, Barbara
    Cosyns, Bernard
    Cowie, Martin R.
    Fitzsimons, Donna
    Fraser, Alan G.
    Jaarsma, Tiny
    Kirchhof, Paulus
    Mauri, Josepa
    Mindham, Richard
    Sanders, Julie
    Schiele, Francois
    Torbica, Aleksandra
    Zwisler, Ann Dorthe
    EUROPEAN HEART JOURNAL, 2023, 44 (36) : 3405 - 3422